{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05769478",
            "orgStudyIdInfo": {
                "id": "IRB00091315"
            },
            "organization": {
                "fullName": "Wake Forest University Health Sciences",
                "class": "OTHER"
            },
            "briefTitle": "Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA",
            "officialTitle": "A Proof of Concept Study of the Effect of Amifampridine (Firdapse\u00ae) on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA (Botox\u00ae, BTX-A)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "effect-of-amifampridine-on-neuromuscular-transmission-in-patients-treated-with-onabotulinumtoxina"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-03",
            "studyFirstSubmitQcDate": "2023-03-03",
            "studyFirstPostDateStruct": {
                "date": "2023-03-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Wake Forest University Health Sciences",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "if amifampridine can improve neuromuscular transmission in muscles previously injected with OnabotulinumtoxinA (BTX-A)",
            "detailedDescription": "Amifampridine may also be effective in treating the sequelae of botulinum toxin injections and this study will determine if neuromuscular transmission as measured by single fiber electromyography is improved in patients treated with BTX-A following administration of amifampridine"
        },
        "conditionsModule": {
            "conditions": [
                "Botulism",
                "Iatrogenic Botulism"
            ],
            "keywords": [
                "botulinum toxin injections",
                "Systemic botulism",
                "neuromuscular transmission",
                "single fiber electromyography",
                "amifampridine"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "before-after study that will measure neuromuscular jitter before and after administration of amifampridine",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Amifampridine will be orally administered to study participants",
                    "type": "EXPERIMENTAL",
                    "description": "Amifampridine will be orally administered to study participants following completion of the baseline SFEMG. Post-dose SFEMG will commence at 30 minutes following dosing and will be completed within 30 minutes. The participant will remain under observation in the Diagnostic Neurology suite for 2 hours after dosing so it is estimated that the entire protocol including monitoring will be completed within 2-3 hours.",
                    "interventionNames": [
                        "Drug: Amifampridine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Amifampridine",
                    "description": "a single dose of amifampridine (20mg) will be orally administered",
                    "armGroupLabels": [
                        "Amifampridine will be orally administered to study participants"
                    ],
                    "otherNames": [
                        "Firdapse"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of abnormal pairs",
                    "description": "Wilcoxon's test for paired data will be used to analyze baseline and post-treatment percent abnormal pairs",
                    "timeFrame": "Hour 3"
                },
                {
                    "measure": "Percentage of Jitter",
                    "description": "Wilcoxon's test for paired data will be used to analyze baseline and post-treatment mean jitter",
                    "timeFrame": "Hour 3"
                },
                {
                    "measure": "Percentage of pairs that show blocking",
                    "description": "Wilcoxon's test for paired data will be used to analyze baseline and post-treatment percent blocking",
                    "timeFrame": "Hour 3"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age: 18-80 years of either gender and of any racial background\n* Underwent BTX-A injection of facial muscles including frontalis with a total dose between 100-200 units between 80 and 150 days prior to study\n* Have decision-making capacity to provide informed consent to study drug dosing and Single Fiber Electromyography (SFEMG)\n\nExclusion Criteria:\n\n* History of cardiac arrhythmia\n* History of seizures or uncontrolled asthma\n* History of renal or hepatic disease\n* History of any generalized neuromuscular disease\n* History of Bell's Palsy or facial nerve trauma\n* History of treatment with or sensitivity to amifampridine, 3,4 diaminopyridine (DAP) or 4-aminopyridine (Ampyra\u00ae)\n* Currently experiencing sequelae of previous BTX-A treatment\n* Current use of pyridostigmine (known to alter neuromuscular transmission)\n* Use of any investigational drug or device within 30 days of enrollment",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Katherinne S Velasquez",
                    "role": "CONTACT",
                    "phone": "336.716.6031",
                    "email": "kserrano@wakehealth.edu"
                },
                {
                    "name": "Mozhdeh Marandi",
                    "role": "CONTACT",
                    "phone": "336.713.8577",
                    "email": "mmarandi@wakehealth.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "James B Caress, MD",
                    "affiliation": "Wake Forest University Health Sciences",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Wake Forest University Health Sciences",
                    "status": "RECRUITING",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27157",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Katherinne S Velasquez",
                            "role": "CONTACT",
                            "phone": "336-716-6031",
                            "email": "kserrano@wakehealth.edu"
                        },
                        {
                            "name": "James B Caress, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001906",
                    "term": "Botulism"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003015",
                    "term": "Clostridium Infections"
                },
                {
                    "id": "D000016908",
                    "term": "Gram-Positive Bacterial Infections"
                },
                {
                    "id": "D000001424",
                    "term": "Bacterial Infections"
                },
                {
                    "id": "D000001423",
                    "term": "Bacterial Infections and Mycoses"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000020511",
                    "term": "Neuromuscular Junction Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000020258",
                    "term": "Neurotoxicity Syndromes"
                },
                {
                    "id": "D000005517",
                    "term": "Foodborne Diseases"
                },
                {
                    "id": "D000011041",
                    "term": "Poisoning"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5184",
                    "name": "Botulism",
                    "asFound": "Botulism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6247",
                    "name": "Clostridium Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M4722",
                    "name": "Bacterial Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M19252",
                    "name": "Gram-Positive Bacterial Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M12136",
                    "name": "Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M4721",
                    "name": "Bacterial Infections and Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M22297",
                    "name": "Neuromuscular Junction Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M22080",
                    "name": "Neurotoxicity Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M8641",
                    "name": "Foodborne Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13931",
                    "name": "Poisoning",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T807",
                    "name": "Botulism",
                    "asFound": "Botulism",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4120",
                    "name": "Neurotoxicity Syndromes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077770",
                    "term": "Amifampridine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009465",
                    "term": "Neuromuscular Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000026902",
                    "term": "Potassium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21257",
                    "name": "Botulinum Toxins, Type A",
                    "relevance": "LOW"
                },
                {
                    "id": "M250193",
                    "name": "abobotulinumtoxinA",
                    "relevance": "LOW"
                },
                {
                    "id": "M5183",
                    "name": "Botulinum Toxins",
                    "relevance": "LOW"
                },
                {
                    "id": "M1902",
                    "name": "Amifampridine",
                    "asFound": "Lymphatic Mapping",
                    "relevance": "HIGH"
                },
                {
                    "id": "M23171",
                    "name": "Potassium Channel Blockers",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                }
            ]
        }
    },
    "hasResults": false
}